(Q44640097)

4 December 2017

title

Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population (English)

1 reference

4 December 2017

1 reference

Yingjun Zhou

1

1 reference

4 December 2017

Denise M Boudreau

series ordinal

2

1 reference

4 December 2017

Andrew N Freedman

series ordinal

3

1 reference

4 December 2017

publication date

30 May 2013

1 reference

Pharmacoepidemiology and Drug Safety

4 December 2017

published in

1 reference

4 December 2017

volume

23

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

43-50

1 reference

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

4 December 2017

cites work

1 reference

The mechanism of action of aspirin

21 January 2018

1 reference

Aspirin in the treatment and prevention of cardiovascular disease: current perspectives and future directions

21 January 2018

1 reference

The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease

21 January 2018

1 reference

Aspirin for the primary prevention of cardiovascular events: recommendation and rationale

21 January 2018

1 reference

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

21 January 2018

1 reference

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

21 January 2018

1 reference

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

21 January 2018

1 reference

Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study

21 January 2018

1 reference

Regular aspirin use and breast cancer risk in US Black women

21 January 2018

1 reference

Aspirin use and reduced risk of fatal colon cancer

21 January 2018

1 reference

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer

21 January 2018

1 reference

Aspirin dose and duration of use and risk of colorectal cancer in men.

21 January 2018

1 reference

Regular aspirin use and lung cancer risk

21 January 2018

1 reference

Use of NSAIDs, smoking and lung cancer risk

21 January 2018

1 reference

Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer.

21 January 2018

1 reference

Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers

21 January 2018

1 reference

Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus

21 January 2018

1 reference

The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force

21 January 2018

1 reference

Aspirin and Cancer Prevention and Treatment: Are We There Yet?

21 January 2018

1 reference

ACP Journal Club. Review: daily aspirin reduces short-term risk for cancer and cancer mortality

21 January 2018

1 reference

Aspirin for the prevention of colorectal cancer

21 January 2018

1 reference

Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement

21 January 2018

1 reference

Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk

21 January 2018

1 reference

Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).

21 January 2018

1 reference

A prospective study of aspirin use and the risk of pancreatic cancer in women

21 January 2018

1 reference

Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis

21 January 2018

1 reference

Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study.

21 January 2018

1 reference

Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force

21 January 2018

1 reference

Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma

21 January 2018

1 reference

Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence

21 January 2018

1 reference

Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin

21 January 2018

1 reference

Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study

21 January 2018

1 reference

A prospective study of aspirin use and the risk of gastrointestinal bleeding in men

21 January 2018

1 reference

Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury

21 January 2018

1 reference

Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials

21 January 2018

1 reference

Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking

21 January 2018

1 reference

Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

21 January 2018

1 reference

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

21 January 2018

1 reference

Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Ag

21 January 2018

1 reference

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

21 January 2018

1 reference

Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among U.S. adults

21 January 2018

1 reference

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

21 January 2018

1 reference

Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.

21 January 2018

1 reference

Gender differences in aspirin use among adults with coronary heart disease in the United States

21 January 2018

1 reference

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

Aspirin for prevention of cancer and cardiovascular disease

21 January 2018

1 reference

AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.3463

1 reference

4 December 2017

1 reference